Altitude Acquisition Corp Cl A (ALTU)
10.12 -0.13 (-1.27%) 03/14/24 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Wed, Mar 13th, 2024
Results
download Want to compare other data? Select Fields| Symbol | ALTU | SERA | OCX | ||
| Company | Altitude Acquisition Corp Cl A | Sera Prognostics Inc Cl A | Oncocyte Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.15 | 2.99 | 3.16 | ||
| High | 10.15 | 3.03 | 3.16 | ||
| Low | 10.12 | 2.99 | 3.16 | ||
| Last | 10.12 | 3.02 | 3.16 | ||
| Change | -0.13 | +0.02 | -0.06 | ||
| % Change | -1.27% | +0.67% | -1.86% | ||
| Volume | 68,900 | 1,277 | 796 | ||
| 20-Day Average Volume | 6,220 | 89,725 | 49,145 | ||
| Previous Close | 10.25 | 3.00 | 3.22 | ||
| Industry | Medical Services | Medical Services | Medical Services | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 10.28 | 3.33 | 2.96 | ||
| 20-Day Raw Stochastic | 0.00% | 4.94% | 66.16% | ||
| 20-Day Relative Strength | 33.96% | 34.93% | 54.56% | ||
| Weighted Alpha | +1.90 | -70.92 | -5.88 | ||
| Today's Opinion | 16% Buy | 100% Sell | 72% Buy | ||
| Previous Opinion | 72% Buy | 100% Sell | 72% Buy | ||
| Last Month's Opinion | 64% Buy | 100% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.13% since 03/04/24 | -11.50% since 04/21/25 | +11.81% since 04/21/25 | ||
| Low | 10.12 on 03/13/24 | 2.96 on 04/28/25 | 2.78 on 04/22/25 | ||
| High | 10.31 on 03/05/24 | 3.64 on 04/23/25 | 3.50 on 04/25/25 | ||
| 1-Month | |||||
| %Chg | -1.46% since 02/13/24 | -15.25% since 03/28/25 | +0.31% since 03/28/25 | ||
| Low | 10.12 on 03/13/24 | 2.96 on 04/28/25 | 2.63 on 04/07/25 | ||
| High | 10.36 on 03/04/24 | 3.77 on 03/31/25 | 3.52 on 03/31/25 | ||
| 3-Month | |||||
| %Chg | -1.27% since 12/13/23 | -51.69% since 01/28/25 | +58.62% since 01/28/25 | ||
| Low | 10.12 on 03/13/24 | 2.96 on 04/28/25 | 1.95 on 02/07/25 | ||
| High | 10.36 on 03/04/24 | 6.92 on 01/31/25 | 4.75 on 03/11/25 | ||
| 6-Month | |||||
| %Chg | -0.20% since 09/13/23 | -57.14% since 10/28/24 | +3.87% since 10/28/24 | ||
| Low | 10.12 on 03/13/24 | 2.96 on 04/28/25 | 1.92 on 01/22/25 | ||
| High | 10.45 on 12/06/23 | 9.13 on 12/23/24 | 4.75 on 03/11/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 92,822 | 112,992 | 92,089 | ||
| Shares Outstanding, K | 9,172 | 37,664 | 28,599 | ||
| Annual Sales | 0 | 80,000 | 1,880,000 | ||
| Annual Net Income | 9,340,000 | -32,900,000 | -60,660,000 | ||
| Last Quarter Sales | 0 | 20,000 | 1,490,000 | ||
| Last Quarter Net Income | -660,000 | -8,580,000 | -33,510,000 | ||
| 60-Month Beta | -0.05 | 0.96 | 0.97 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/16/23 | -0.25 on 03/19/25 | 0.48 on 03/24/25 | ||
| Latest Earnings Date | N/A | 05/07/25 | 05/21/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||